← Back to Search

Gas Therapy

Coronary Artery Disease (CAD) Subjects for Coronary Artery Disease (NIMO-CAD Trial)

N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults > 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 hours
Awards & highlights

NIMO-CAD Trial Summary

This trial is testing if using carbon dioxide can help measure blood flow in the hearts of people with heart disease.

Who is the study for?
This trial is for individuals with coronary artery disease. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions and agree to the study's procedures.Check my eligibility
What is being tested?
The trial is testing RespirAct, a method using carbon dioxide to assess blood flow in the coronary arteries. It's a pilot study focusing on how safe and feasible this technique is for patients with heart issues.See study design
What are the potential side effects?
Since detailed side effects are not listed, generally speaking, introducing carbon dioxide might cause discomfort or changes in breathing patterns; however, specifics will be monitored during the trial.

NIMO-CAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.

NIMO-CAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ratio of Maximum Signal Intensity (MSI) by BOLD MRI
Ratio of Maximum Signal Intensity (MSI) by FFP MRI

NIMO-CAD Trial Design

1Treatment groups
Experimental Treatment
Group I: Coronary Artery Disease (CAD) SubjectsExperimental Treatment1 Intervention
Subjects with a of coronary artery disease will undergo computer-controlled gas challenges.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
983 Previous Clinical Trials
981,212 Total Patients Enrolled
9 Trials studying Coronary Artery Disease
988 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for participants in this study currently ongoing?

"As per the details available on clinicaltrials.gov, recruitment for this trial is presently closed. The initial posting date of this study was 1st July 2024, with the latest update made on 2nd February 2024. Although this specific trial has concluded participant enrollment, there are a substantial number of 564 other ongoing studies actively seeking individuals to participate in various research initiatives."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
Rohan Dharmakumar 2024. "Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06253884.
All > Coronary Artery Disease
~20 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top